M. Galanter et al., The impact of managed care on substance abuse treatment: A report of the American Society of Addiction Medicine, J ADDICT D, 19(3), 2000, pp. 13-34
This report examines the impact of managed care (MC) and related developmen
ts on substance abuse treatment, and evaluates how it has been associated w
ith a decline in the availability of proper treatment for many addicted pat
ients. A trend toward carve-out and for-profit MC organizations is associat
ed with lower financial incentives for intensive treatment than in earlier
staff-model and not-for-profit MC organizations. The value of substance abu
se insurance coverage has declined by 75% between 1988 and 1998 for employe
es of mid-to large-size companies, compared with only an 11.5% decline for
general health insurance. The shift towards MC has also been associated wit
h a drastic reduction in frequency and duration of inpatient hospitalizatio
n, and there is no clear evidence that this reduction has been offset by a
corresponding increase in outpatient support. In a survey of physicians tre
ating addiction, the majority felt that MC had a negative impact on dt toxi
fication and rehabilitation, and on their ethical practice of addiction med
icine.